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1) Matsuo M., Sakurai H., Koizumi K., and Saiki I.: Curcumin inhibits the formation of 
capillary-like tubes by rat lympahatic endothelial cels. Cancer Lett., 251: 288-295, 2007. 
Abstract: The natural pigments curcumin and berberine have been shown to exhibit a variety of 
pharmacologic effects including anti-inflammatory, anti-cancer, and anti-metastatic properties. Here, we 
investigated the anti聞lymphangiogeniceffect with an in vitro tube-forming model using conditionally 
immortalized lymphatic endothelial TR-LE cels, a newly established cel line originating from the 
thoracic duct of a transgenic rat expressing the temperature-sensitive SV 40 large T-antigen. Curcumin, 
but not berberine, exhibited a dose-dependent inhibition of the formation of capillary-like tubes by TR-LE 
cells without affecting cel viability and adhesion to Matrigel. To address the molecular mechanisms 
involved, we performed experiments with specific inhibitors against putative targets of curcuminラ
including IKB kinase (IKK), epidermal growth factor receptor (EGFR), phosphatidylinositol-3 kinase 
(PI3K)/Akt, and matrix metalloproteinases (MMPs). While the IKK-2 inhibitor VI and EGFR tyrosine 
kinase inhibitors gefitinib and PD153035 had no effect, both the PI3K inhibitor LY294002 and the MMP 
inhibitor GM6001 shortened the tubes by approximately 50%. Western blot analysis and gelatin 
zymography revealed that curcumin, but not berberineラhasan inhibitory effect on the phosphorylation of 
Akt and enzymatic activity of MMP-2 in TR-LE cels. These results suggest that curcumin exerts its 
inhibitory effect on lymphangiogenesis partly through Akt and MMP-2. 
2) Tsunoda S., Nakamura T., Sakurai H., and Saiki I.: Recombinant human fibroblast growth 
factor-2 stimulates expression of endogenous vascular endothelial growth factor to enhance 
the growth and metastasis of implanted mouse melanoma cels. Cancer Sci., 98: 541・548,
2007. 
Abstract: Fibroblast growth factor (FGF)-2 has been considered to play a critical role in 
neovascularization in several印mors;however, its precise role in tumor progression is not fully 
understood. In the present s同dy,we have characterized the role ofFGF-2 in Bl6-BL6 mouse melanoma 
cels, focusing on effects during the initial phase of tumor growth. FGF-2 was injected at the tumor 
inoculation site of dorsal skin during the initial phase. FGF-2 induced marked tumor growth and lymph 
node metastasis. This was well correlated with an increase in neovascularization in the host stroma. 
FGF-2 also recruited inflammatory and mesenchymal cells in host stroma. Marked tumor growth, 
pulmonary metastasis and intensive neovascularization in tumor parenchyma were also observed after a 
single in ection of FGF-2 into the footpad inoculation site. In contrast, repeated i吋ectionsof FGF-2 at a 
site remote from the footpad tumor were ineffective in promoting tumor growth and metastasis. These 
promoting activities of FGF-2 were blocked by local in ections of a glucocorticoid hormone, suggesting 
that host inflammatory responses induced by FGF之 areassociated with FGF-2-induced tumor 
progression. In addition, although FGF-2 did not promote cellular proliferation and vascular endothelial 
growth factor A (VEGFA) mRNA expression in B16-BL6 cells in vitro, FGF-2 induced VEGFA 
expression in host stroma rather than tumor tissue, and local injections of a neutralizing antibody against 
VEGFAinhibited these activities ofFGF-2 in vivo. These results indicate that abundant FGF-2 during the 
initial phase of tumor growth induces VEGFA-dependent intensive neovascularization in host stroma, and 
supports marked tumor growth and metastasis. 
3) Chuethong J., Oda K., Sakurai H., Saiki I., and Leelamanit W.: Cochinin B, a novel 
ribosome-inactivating protein from the seeds of Momordica cochinchinensis. Biol. Pharm. 
Bull, 30: 428・432,2007. 
Abstract: Cochinin B, a novel ribosome-inactivating protein (RIP) with a molecular weight of 28 kDa, 
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was purified from the seeds of Momordica cochinchinensis (Cucurbitaceae). The isolation procedure 
entailed ammonium sulfate precipitationラcation-exchangechromatography on SP Sepharose column and 
size-exclusion chromatography on Superdex 7 5 column with a fast protein liquid chromatography 
(FPLC) system. The first twenty N-terminal amino acid residues ofCochinin B showed homology to type 
I RIPs from other Momordica species. The purified Cochinin B displayed a strong inhibitory activity on 
protein synthesis in the cell-free rabbit reticulocyte lysate system with IC50 of 0.36 nM. Furthermore, it 
exhibited N-glycosidase activity and cytotoxicity against Vero cel line with IC50 higher than 1540 nM. 
Interestingly, Cochinin B manifested strong anti-tumor activities on human cervical epithelial carcinoma 
(HeLa）ラ humanembryonic kidney (HEK293) and human small cel lung cancer (NCI-H187) cel lines 
with IC50 of 16.9ラ114and 574 nM, respectively. 
4) Koizumi k吋 KozawaY., Ohashi Y., Nakamura E. S., Aozuka Y., Sakurai H., lchiki K., Doki 
Y., Misaki T., and Saiki I.: CCL21 promotes the migration and adhesion of highly lymph 
node metastatic human nmトsmallcel lung cancer Lu・99in vitro. Oncology Rep., 17: 
1511圃1516,2007. 
Abstract: To develop new therapy strategies for lung cancer, we established an animal model, which 
reflects the clinical features of mediastinal lymph node metastasis of lung cance工Thisstudy was designed 
to determine whether CCL21 induced biological functions associated with the metastasis of highly lymph 
node metastatic human non-small cel lung cancer (NSCLC) selected by our model. Orthotopic 
intrapulmonary implantation of human NSCLC (Llト99and A549) was performed to analyze the 
metastatic characteristics of these cels. The expression of CCR 7ラwhichis a receptor of CCL2 lラwas
detected using CCL19 [also called EBil-ligand chemokine (ELC)]-Fc chimera by flow cytometric 
analysis. The effects of CCL21 on the migration, adhesion・ and growth of human NSCLC were 
investigated. After orthotopic implantation of human NSCLC cel lines, Lu-99ラ butnot A549, 
metastasized to mediastinal lymph nodesラforminglarge size nodules, and expressed CCR 7 on the surface. 
Accordinglyラ itsligand CCL21 induced chemotactic migration and alpha4betal-mediated adhesion to 
VCAM-1 of Lu-99. The expression of CCR7 and vigorous responses to its ligand CCL21 potentially 
account for lymph node metastasis of a human NSCLC line Lu-99. 
5) Shambharkar P.B吋 BlonskaM., Pappu B.P.吋 YouY吋 SakuraiH吋 DarnayB吋 andLin X.: 
Phosphorylation and ubiquitination of the IKB kinase complex by two distinct signaling 
pathways. EMBO J吋 26:1794-1805, 2007. 
Abstract: The IKB kinase (IKK) complex serves as the master regulator for the activation of NF《Bby 
various stimuli. It contains two catalytic subunits, IKKαand IKK~， and a regulatory subunit，♂ 
IKKy/NEMO. The activation of IKK complex is dependent on the phosphorylation of IKKα／~ at its 
activation loop and the K63-linked ubiquitination of NEMO. However, the molecular mechanism by 
which these inducible modifications occur remains undefined. Here, we demonstrate that CARMA!, a 
key scaffold molecule, is essential to regulate NEMO ubiquitination upon 下cel receptor (TCR) 
stimulation. However.ラthephosphorylation of IKKα／~ activation loop is independent of CARMA 1 or 
NEMO ubiquitination. Furtherラweprovide evidence that TAKI is activated and recruited to the synapses 
in a CARMAl-independent manner and mediate IKKa／~ phosphorylation. Thus, our study provides the 
biochemical and genetic evidence that phosphorylation of IKKa／~ and ubiquitination of NEMO are 
regulated by two distinct pathways upon TCR stimulation. 
6) Singhirunnusorn P., Ueno Y., Matsuo M., Suzuki S., Saiki I. and Sakurai H.: Transient 
suppression of ligand-mediated activation of epidermal growth factor receptor by TNF-a 
through the TAK1-p38 signaling pathway. J. Biol. Chem円 282:12698・12706,2007. 
Abstract: Epidermal growth factor receptor (EGFR) has been shown to be activated by specific ligands 
as well as other cellular stimuli including tumor necrosis factor聞α（TNF－α）.In the present study, we found 
? ?
that cellular stress suppressed ligand-mediated EGFR activity. Both TNF－αand osmotic stress rapidly 
induced phosphorylation of EGFR. This phosphorylation of EGFR and the activation of 
mitogen-activated protein kinases and NF《 Boccurred independently of the shedding of extracellular 
membrane-bound EGFR ligands and intracellular EGFR tyrosine kinase activity. Transforming growth 
factor-P-activated kinase 1 (TAKI) was involved in the TNF-a-induced signaling pathway to EGFR. In 
additionラexperimentsusing chemical inhibitors and small interfering RNA demonstrated that p38αis a 
common mediator for the cellular stress-induced phosphorylation of EGFR. Surprisingly, the modified 
EGFR was not able to respond to its extracellular ligand due to transient internalization through the 
clathrin-mediated mechanism. Furthermoreラ turnoverof p38 activation led to dephosphorylation and 
recycling back to the cell surface of EGFR. These results demonstrated that TNF－αhas opposite 
bi白nctionalactivities in modulating the function of the EGFR. 
7) Saiki I.: In vivo anti-metastatic action of Ginseng saponins is based on their intestinal 
bacterial metabolites after oral administration. J. Ginseng Res吋 31:1-13, 2007. 
8) Hojo S円 Koizumik円 Tsuneyamak刊 AritaY., Cui Z., Shinohara k叫 MinamiT吋 Hashimoto
I円 NakayamaT刊 SakuraiH叫 TakanoY.吋 Yoshie0., Tsukada K., and Saiki I.: High level 
expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and 
increased tumor-infiltrating lymphocytes in cololectal cancer. Cancer Res刊 67:4725-4731, 
2007. 
Abstract: CXCL 16 is a new member of the chemokine superfamily, which exists in a transmembrane as 
well as a soluble form. Its receptor CXCR6 is detected on CD4（十） T cellsラCD8(+) T cellsラandnatural 
killer T cels. Hereラwereport a significant correlation of CXCL 16 expression by tumor cells with the 
infiltration of T cells and prognosis in colorectal cancer (CRC). We first found that CXCLl 6 expression 
was consistently up-regulated more in tumor tissues than in normal mucosa derived from the same CRC 
patients. Four human CRC cell lines also expressed CXCLl 6 rnRNA and secreted soluble CXCLl 6. We 
next examined the expression of CXCLl 6 and infiltration of lymphocytes in CRC specimens (n = 58) by 
immunohistochemistry. CRC patients with high levels of CXCL16 expression (n = 43) had higher levels 
of CD4(+) and CD8(+) tumor-infiltrating lymphocytes (TIL; P < 0.01) than those with low levels of 
CXCLl 6 expression (n = 15). Furthermore, the high CXCLl 6 expression group showed significantly 
better prognosis than the low CXCLl 6 expression group (P < 0.05). Collectivelyラourdata suggest that the 
expression of CXCLl 6 by tumor cells enhances the recruitment of TILs, thereby bringing about a better 
prognosis in CRC. ThusラCXCL16 is a new prognostic biomarker and may be useful for the development 
of a more effective therapeutic strategy for CRC. 
9) lgarashi Y., Trujillo M.E吋 Martinez-MolinaE円 YanaseS., Miyanaga S叫 Obata T吋 Sakurai
H吋 SaikiS刊 FujitaT吋 andFurumai T.: Antitumor anthraquinones from an endophytic 
actinomycete Micromonospora lupini sp. nov. Bioorganic Med. Chem. Letts., 17: 3702・3705,
2007. 
Abstract: Two novel anthraquinones, lupinacidins A (1) and B (2), have been isolated from the culture 
broth of a new endophytic actinomycete belonging to the genus Micromonospora. Lupinacidins were 
found to show significant inhibitory effects on the invasion of murine colon 26-L5 carcinoma cells 
without inhibiting cell growth. 
10) Nozaki K., Goto H叫 NakagawaT., Hikiami H円 Koizumik刊 SibaharaN刊 ShimadaY.: Effect 。fkeishibukuryougan on vascular function in adjuvant-induced arthritis rats. Biol. Pharm. 
Bull., 30: 1042-1047, 2007. 
Abstract: It is known that rheumatoid arthritis (RA) accelerates atherosclerosis. Further, the soluble form 
of vascular adhesion molecule-I (VCAM-1) is known as a predictive marker of atherosclerosis in RA 
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patients. We reported that keishibukuryogan, one of the Kampo formulas, improved articular symptoms 
and decreased soluble VCAM-1 in patients with RA. In adjuvant-induced arthritis (AIA) rats, an animal 
model of RAラitis known that endothelial function is injured by inflammation. So, we investigated the 
effect of keishibukuryogan on endothelial function in AIA rats. Lewis rats were divided into controlラAIA
controlラandAIA with keishibukuryogan groups. The AIA with keishibukuryogan group was fed 3% 
keishibukuryogan contained in normal chow. On day 25 after i吋ectionof Mycobacterium butyricumラ
endothelium-dependent relaxation by acetylcholine in the AIA control group was suppressedラbutit was 
improved in the AIA with keishibukuryogan group. The contractions by xanthine/xanthine oxidase in 
both AIA rats increased, but that in keishibukuryogan decreased compared to the AIA control group. 
Plasma levels oflipid peroxide increased in the AIA control group, but keishibukuryogan decreased these 
levels. Plasma levels of nitric oxide (NO) increased in both AIA groups. The expressions of endothelial 
NO synthase, inducible NO synthase and VCAM-1 of thoracic aorta were investigated by western 
blotting. These expressions increased in the AIA control group, but were restricted in the AIA with 
keishibukuryogan group. We considered that keishibukuryogan protected the endothelial function of AIA 
rats mainly by its anti-oxidative effect. 
11) Matsuo M., Yamada S., Koizumi K., Sakurai H., and Saiki I.: Tumor-derived fibroblast 
growth factor-2 exerts lymphangiogenic effects through Akt/mTOR/p70S6 kinase pathway 
in rat lymphatic endothelial cels. Eur. J. Cancer., 43: 1748-1754, 2007. 
Abstract: Fibroblast growth factor-2 (FGF-2) has been shown to induce both angiogenesis and 
lymphangiogenesis in the mouse comeum; howeverラ the signalling mechanism underlying 
FGF-2-induced lymphangiogenesis remains unknown. Here we investigated the effect ofFGF-2 on newly 
developed temperature-sensitive rat lymphatic endothelial (TR-LE) cels. The supernatant of PC-3 
prostate cancer cells facilitated tube-like formation in TR-LE cels, and formation was inhibited by 
neutralising antibodies against FGF-2. The addition of FGF-2 stimulated tube-like formation as well as 
proliferation and chem~tactic migration of TR-LE cels. Blockade of the Akt signalling pathway by 
LY294002 abolished the elongation of tubes induced by FGF-2ラwhereasinhibition of the extracellular 
signal-regulated kinase (ERK) signalling pathway had no effect. Rapamycin abrogated the 
phosphorylation of p70S6kinase and consistently inhibited the formation of tubes induced by FGF-2. 
Furthermoreラtube-likeformation induced by the supernatant of PC-3 cells was inhibited by LY294002 or 
rapamycin. These data suggest that FGF-2 exerts lymphangiogenic effects by activating the 
Akt/mammalian target of rapamycin (mTOR)/p70S6kinase pathway in lymphatic endothelial cels, and 
that the pathway provides a potent target for tumour lymphangiogenesis. 
12) Kammasud N., Boonyarat C円 TsunodaS., Sakurai H., Saiki I., Grierson D.S. and 
Vajragupta 0.: Novel inhibitor for fibroblast growth factor receptor tyrosine kinase. Bioorg. 
Med. Chem. Lett., 17: 4812-4818, 2007. 
Abstract: NP603ラthe6・－dimethoxyphenyl indolin-2-oneラwasdesigned as FGF receptor 1 inhibitor by 
computational study. NP603 was synthesized and found to be more active against endothelial 
proliferation ofHUVEC after the rhFGF-2 stimulation than SU6668 with minimum effective dose of 0.4 
microM but with similar potency as SUI 6g. NP603 inhibited the tyrosine phosphorylation in FGF 
receptor and the activation of extracellular signal-regulated kinase and c-Jun-N-terminal-kinase after the 
rhFGF-2 stimulation. The increase in activity of NP603 supports the role of Lys514 movement in 
ligand-receptor binding in modeling study as the movement accommodates the hydrophobic interaction at 
the receptor pocket leading to the enhancement of binding capacity. 
13) Ogawa K., Kojima I吋 MatsumotoC., Kamegai S吋 OyamaT円 ShibagakiY., Muramoto H., 
Kawasaki I円 FujinagaH刊 TakahashiK., Hikiami H., Goto H., Kiga C吋 Koizumik吋 Sakurai
H., Shimada Y吋 YamamotoM., Terasawa K., Takeda S刊 andSaiki I.: Identification of a 
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predictive biomarker for the beneficial effect of a Kampo (Japanese traditional) medicine 
keishibukuryogan in rheumatoid arthritis patients. Clin. Biochemistry., 40: 1113・1121,2007. 
Abstract: OBJECTIVES: Kampo (Japanese traditional herbal) medicines are now ethically used in Japan 
as pharmaceutical grade prescription drugs. Howeverラ thereare distinct groups of responders and 
non-responders to Kampo medicines. We searched for biomarker candidates to discriminate responders 
from non-responders to keishibukuryogan (KBG); one of the most frequently used Kampo medicines. 
DESIGN AND METHODS: A combination of SELDI technology and a decision tree analysis with 
proprietary developed bioinformatics tools was applied to 41 (32 for tree construction and 9 for validation 
test) plasma samples obtained from rheumatoid arthritis (RA) patients. A candidate biomarker protein 
was identified using LC-MS/MS. RESULTS: The constructed tree with measurable reliability contained 
only a single peak which was identified as haptoglobin alpha 1 chain (Hpalphal). CONCLUSION: 
Hpalphal is a biomarker candidate for discriminating responders from non-responders to KBG treatment 
for RA. The present results may open the way to the establishment of "evidence-based" complementary 
and alternative medicine. 
14) Suzuki S吋 SinghirunnusornP., Mori A., Yamaoka S円 KitajimaI., Saiki I., and Sakurai H.: 
Constitutive activation of TAKl by HTLV-1 Tax-dependent overexpression of TAB2 induces 
activation of JNK-ATF2 but not IKK-NF四KB.J. Biol. Chem., 282: 25177・25181,2007. 
Abstract: HTLV-1 Tax oncoprotein induces persistent activation of the transcription factor NF-KB and 
CREB ( cAMP-response element-binding protein)/ ATF. Transforming growth factor-B-activated kinase 1 
(TAKI) has been shown to play a critical role in these transcription factors. Here, we found that TAKI 
was constitutively activated in Tax-positive HTLV-I-transformed T cels. Tax induced persistent 
overexpression of TAKI・bindingprotein 2 (TAB2), but not TAB3ラ whichis essential for TAKI 
activation. SurprisinglyラTAKIwas not involved in the activation of NF-KB. On the other hand，丹~Kand
p38 mitogen-activated protein kinases were activated by TAKI. In addition, ATF2ラbutnot CREB, was a 
target for the TAKI-JNK pathwayラ andp38 negatively regulated TAKI activity through TABI 
phosphorylation. These results indicate that Tax-mediated TAKI activation is important for the activation 
of ATF2 rather than NF-KB. 
15) Saitoh Y., Koizumi k吋 SakuraiH叫 Minami T., and Saiki I.: RANKL・induced
down-regulation of CX3CR1 via PI3K/Akt signaling pathway suppresses 
Fractalkine/CX3CL1-induced cellular responses in RAW264.7 cels. Biochem. Biophys. Res. 
Commun., 364: 417-422, 2007. 
Abstract: The receptor activator of nuclear factor-KB ligand (RANKL) is essential for osteoclast 
differentiation. In this s肌dy,we examined the effects of RANKL on chemokine receptor expression in 
osteoclast precursor cels, RAW264.7 cels. CX3CL1 (also called Fractalkine) receptor, CX3CRI mRNA 
expression, was rapidly reduced by treatment with RANKL in contrast to the increased expression of 
CCRI and tartrate-resistant acid phosphatase (TRAP). This reduction occurred within 12h and was 
maintained for 5days during osteoclastogenesis. Inhibitors of phosphatidylinositol 3-kinase (PI3K) and 
Akt, but not mitogen-activated protein kinases, restored the RANKL-induced reduction of CX3CRI 
mRNA. The stability of CX3CRI mRNA was not changedラ suggestingtranscriptional repression by 
RANKL. The down-regulation of CX3CRI mRNA correlated with the suppression of CX3CL1-induced 
activation of Akt and ERK as well as chemotaxis. These results suggest a potential role for decreased 
CX3CL1-CX3CRI interaction in osteoclastogenesis. 
く〉総説
I) 済木育夫：薬学教育と漢方 リレー寄稿，富山大学の場合⑦ 薬学教育と漢方に関する
最近の動向など，漢方と最新治療.16: l I 7-I20, 2007. 
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2) 済木育夫：特集「進化するがん治療の展望」一薬剤師がチームの一員として知っておく
べき基礎知識一 2. 免疫賦活：基礎 一漢方薬による免疫賦活とがん転移の抑制一，
医薬ジャーナル43:91-99, 2007. 
3) 楼井宏明： TAKI活性化の分子機構と生理機能の新展開生化学，79:883-887, 2007. 
4) Koizumi K., Rojo S., Akashi T.ラYasurnotoK., and Saiki I.: Review Articles, Chernokine receptors 
in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci., 
































10) Saiki I.: Inhibition of intrahepatic metastasis produced by orthotopic implantation of 
hepatocellular carcinoma by curcumin. International Symposium on Research and Development 





12) Saiki I.: Proteomic analysis of pathogenic alteration (Sho) diagnosed by Kampo medicine and 
establishment of tailor-made treatment. Joint Symposium “Evidence-based Approach to 
Traditional Medicine and Modem Medicine" , organized by Innovative Team Program in Peking 


































24) Min-Kyung Choo，楼井宏明，小泉桂一，済木育夫： HUVECの管腔形成における TAKI
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39) Isono T., Kim C-J.ラSakuraiH.ラOkadaY. and Inoue H.: Periostin activates TAKI and suppresses 
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40} Yasuda K.ラNagakawa 0., Akashi T.ラKoizumiK., Saiki I. and Fuse H.: serum active hepatocyte 
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2007, 10ラ3-5ラ横浜．
41) Matsuo M.ラKoizumiK., Sakurai H. and Saiki I.: Curcumin inhibits the formation of capillary-like 
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